Parkwalk Advisors

Parkwalk is a London-based independent investment management firm. We seek to generate significant capital gains through venture capital investing, enhanced by the attractive tax relief provided by the Enterprise Investment Scheme (EIS).

Parkwalk entered this investment space in 2009, anticipating a fresh wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth. These incentives are already leading to higher company valuations, and higher returns for investors.

Our portfolio is focused on companies spun out from the UK’s leading universities and other research-intensive institutions to develop and commercialise relevant new technology. Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow.

Our Funds aim for investor returns over four to eight years, via balanced portfolios of companies with varying investment stages to spread maturity and sector risk.

Show more
HQLondon, GB
Cybersecurity ratingBMore
Parkwalk Advisors was founded in 2009 and is headquartered in London, GB

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Parkwalk Advisors

Neil Cameron

Neil Cameron

Kathy Samii

Kathy Samii

Alastair Kilgour

Alastair Kilgour

Moray Wright

Moray Wright

Alun Williams

Alun Williams

Investment Director
Martin Glen

Martin Glen

Investment Director
Show more

Parkwalk Advisors Office Locations

Parkwalk Advisors has an office in London
London, GB (HQ)
WarWick House, 25 Buckingham Palace Rd, Westminster
Show all (1)

Parkwalk Advisors Online and Social Media Presence

Embed Graph

Parkwalk Advisors Blogs

PharmEnable – raises £1.8 million for drug discovery expansion

PharmEnable, a Cambridge-based drug discovery company using a combination of medicinal chemistry and AI approaches to design the next generation of highly specific and 3-dimensional small molecule drugs, announces it has closed a £1.8 million seed financing to support its transition into a drug deve…

Parkwalk – why invest in VC now?

We are frequently asked why is now a good time to be investing into venture capital, especially at this time. So these are our thoughts and a version of this was published in WealthBriefing. Invest in VCs now – and it should be equity “And why do we fall, Bruce? So we can learn to The post Parkwalk …

Qkine – £1.5M series A funding from leading life science investors

Qkine secures £1.5M series A funding from leading life science investors to accelerate global scale-up and make key hires to leadership team Cambridge, UK 08 June 2020: Qkine – a specialist developer and manufacturer of proteins for stem cell, organoid and regenerative medicine applications – today …

Oxford Flow – secures £8.45m investment

Oxford Flow secures £8.45m investment to accelerate oil and gas product deployment Oxford, UK, 3rd June 2020 – Oxford Flow, the flow control equipment specialist for oil, gas, water and industrial process industries, has raised £8.45m to fuel the company’s expansion across all markets and oil and ga…

Flusso – raises $5.7m Series A

Flusso raises $5.7m Series A to disrupt $8bn gas- and liquid-flow monitoring market  University of Cambridge spinout’s sensor miniaturisation technology improves effectiveness of consumer, industrial, automotive, and medical products  Cambridge, 2 June 2020 – Flusso, a semiconductor company spun out…

Parkwalk – (Deep) tech will save us

The coronavirus pandemic will be a watershed for the UK economy, encouraging a refocusing towards science and technology – and investor outlooks will change to match. Moray Wright, Parkwalk CEO, gives his thoughts on how Deeptech investment will increase post this crisis. A version of this article a…
Show more

Parkwalk Advisors Frequently Asked Questions

  • When was Parkwalk Advisors founded?

    Parkwalk Advisors was founded in 2009.

  • Who are Parkwalk Advisors key executives?

    Parkwalk Advisors's key executives are Neil Cameron, Kathy Samii and Alastair Kilgour.

  • What is Parkwalk Advisors revenue?

    Latest Parkwalk Advisors annual revenue is £5 m.

  • Where is Parkwalk Advisors headquarters?

    Parkwalk Advisors headquarters is located at WarWick House, 25 Buckingham Palace Rd, Westminster, London.

  • Where are Parkwalk Advisors offices?

    Parkwalk Advisors has an office in London.

  • How many offices does Parkwalk Advisors have?

    Parkwalk Advisors has 1 office.